Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Limagrain Licenses Genome-Editing Technologies From Qi Biodesign
1+ hour, 41+ min ago (289+ words) Limagrain has entered a global licensing agreement with Beijing Qi Biodesign Biotechnology Co. Ltd. that will give the seed company access to a portfolio of genome-editing technologies for field and vegetable crops. The agreement includes immediate access to a CRISPR…...
Startup promising to scale custom CRISPR therapies abruptly scraps plans
2+ hour, 3+ min ago (191+ words) By Jason Mast and Allison DeAngelis Aurora Therapeutics, a startup focused on building personalized gene-editing drugs, has scrapped its lead program and slashed staff, just seven months after it launched, STAT has learned. A company spokesperson declined to say how…...
Glymphatic gene therapy platform targets brain’s glial cells precisely
6+ hour, 25+ min ago (570+ words) Researchers at the University of Rochester have developed a gene therapy platform that uses the brain’s own glymphatic transport system to distribute therapeutic genes throughout the brain. This method could provide a potential new approach for treating neurological disorders including…...
How Transposable Elements Adapt in Clinically Important Adult Stem Cells
2+ hour, 46+ min ago (585+ words) Bioengineer.org...
Treating Disease with a "Gene Switch" Instead of Medicine? Scientists Take a Major First Step
13+ hour, 8+ min ago (795+ words) By Surya Prakash Josyula Imagine visiting a doctor a few decades from now. Instead of writing a prescription, the doctor says, “The problem isn’t your body. It’s a gene switch that has turned on at the wrong time. Let’s fix…...
Cryopreservation in cell therapy: Reducing variability from the start
11+ hour, 2+ min ago (774+ words) Cell therapies are among the most complex treatment modalities currently moving through clinical development, and much of that complexity sits in the supply chain. From patient cell collection to manufacturing and delivery, every operational decision can affect consistency, scalability, and…...
ROIS and University of Tokyo complete medaka genome and uncover sex chromosome evolution clues
19+ hour, 47+ min ago (383+ words) High-precision sequencing fills 1,000 gaps in Hd-rR, HNI and HSOK lines and reveals repeat regions tied to chromosome stability and fin morphology In the first genome analysis 20 years ago, the researchers used the traditional base sequence analysis method 'Sanger sequencing' to…...
CGTCON 2026: Join the 11th International Cell & Gene Therapy Conference - CMC Vellore & BRIC-inStem Collab
13+ hour, 52+ min ago (32+ words) CGTCON 2026: Join the 11th International Cell & Gene Therapy Conference – CMC Vellore & BRIC-inStem Collab biotecnika.org 9-10 October 2026 at CMC Vellore Early bird registration is now open....
The 10 Biggest Bottlenecks Slowing Drug Development
11+ hour, 33+ min ago (375+ words) Ten industry leaders from the 2026 Power List identify the scientific, clinical, regulatory, and financial barriers holding drug development back The biggest bottleneck slowing progress in drug development is the competition for, and successful recruitment of, patients for participation in clinical…...
CellOrigin Advances In Vivo Cell Therapy Pipeline with ASCO Data and Walvax Partnership
12+ hour, 40+ min ago (140+ words) 03 August 2026 | Monday | News CellOrigin, a biotechnology company focused on next-generation in vivo and in vitro cell therapy technologies, has announced two major progresses in both research and strategic partnership. Through sustained R&D investment, CellOrigin has established a comprehensive in…...